Paris (France), August 25th 2008 – Biospace Lab announces the commercialization of its
new software platform for analysis and processing of images acquired with its preclinical
imaging systems. “M3 Vision™” is a multi-modality software solution combining accurate
quantitation and kinetic analysis with precision export functionality. The initial version of M3
Vision™, designed for analysis of optical images acquired from the Photon IMAGER™
System and available in standard and advanced modes, will be followed by another version
enabling the integration and processing of images acquired from Biospace Lab’s
autoradiography and scintigraphy detection systems. This unique software platform will
soon facilitate the analysis of results obtained with all imaging technologies from Biospace
Lab paving the way for new developments and discoveries in biomedical research.
In addition, Biospace Lab, specializing in optical imaging for in vivo and in actio®
bioluminescence and fluorescence applications with its Photon IMAGER™, will present new
imaging modules to the World Molecular Imaging Congress® in Nice, France, from
September 10 - 13, 2008 ( http://www.wmicmeeting.org/ *):
- “MultiViews”, a module to enable visualization and quantification of four views of the same
animal (dorsal, ventral, and two sides) simultaneously and in real-time and without having
to move the animal or camera;
- “MacroLens” and “MacroToMicro”, modules to include various microscope objectives with
a macro imaging system to bridge the gap between whole-body small animal imaging and
microscopy in one in vivo optical imaging system. For the first time researchers will be able
to observe in real-time, at various resolution levels, physiological and pathological
phenomena in whole animals, organs and cells. With this module, the Photon IMAGER™
becomes the first integrated commercial system able to reveal the world of bioluminescence
at the microscopic level.
For more details on these new developments from Biospace Lab please visit:
*Biospace Lab will have the booth #216 at the World Molecular Imaging Congress® and will
handle an industry workshop on Friday, September the 12th of 2008
These innovations from Biospace Lab for the researchers, lead the way to radically new
protocols for the observation and the comprehension of the life.
Biospace was founded in 1996 by Nobel Prize winner Georges Charpak to provide fellow researchers in
biology with innovative imaging tools based on his discoveries in high-energy physics and particle
detection. Since then, biospace has pursued and created strong links with the medical, pharmaceutical and
scientific communities to bring relevant and creative solutions to biomedical imaging needs.
Biospace lab (www.biospacelab.com) focuses on high-performance imaging equipment for pre-clinical
research in drug discovery and biology. The company has developed in this field a comprehensive portfolio
of in vitro, in vivo and now in actio® multimodality small animal imaging solutions used by almost every
major pharmaceutical company and many prestigious academic centers worldwide.
Biospace lab headquarters, development and production facilities are located in central Paris, France and
the company has a subsidiary in Cambridge, MA USA.